Introduction: While SARS-CoV-2 vaccines provide significant protection against severe COVID-19 illness, breakthrough infections have sparked confusion among patients about the effectiveness of vaccination. It's unclear if (or to what extent) breakthrough infection experiences impact public perceptions of COVID-vaccine effectiveness, though the answer may have significant implications for public health communications and ongoing vaccine acceptance.
Methods: We conducted a survey of 2,500 adults in the United States (February 27 - March 9, 2023) in order to better understand the relationship between breakthrough COVID-19 infections and perceived vaccine effectiveness. Survey respondents were selected using a stratified, quota sampling approach to ensure representativeness; analysis was conducted on responses from 1,928 participants who received a COVID-19 vaccine.
Findings: Among those who tested positive for COVID-19 after being vaccinated, 21.18 % said that COVID-19 vaccines had been "less effective" than they initially expected, compared with 10.0 % of those who did not experience any breakthrough infections (X = 75.551; φ = 0.198; p ≤ 0.001). Those who experienced their own breakthrough infection were 1.37 times less likely to report perceived vaccine efficacy, while those whose family members experienced a breakthrough infection were 1.64 times less likely to report the same, ceteris paribus. The largest effect was observed among those who experienced both a personal and familial breakthrough infection. This group was almost two times less likely to describe COVID-19 vaccines as "very effective".
Discussion: Breakthrough infections correlated with lower overall levels of perceived vaccine effectiveness, even after accounting for demographic and political considerations. Moving forward, public officials and health professionals should work proactively to ensure that breakthrough infections are understood in the broader context of overall vaccine effectiveness.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.vaccine.2023.11.032 | DOI Listing |
BMC Ophthalmol
January 2025
Department of Ophthalmology, Linkou main branch, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
Background: While vaccination remains crucial in mitigating the impact of the COVID-19 pandemic, several ocular adverse events has been reported, including Acute Zonal Occult Outer Retinopathy (AZOOR) complex.
Case Presentation: A 31-year-old female presented declined best corrected visual acuity (BCVA) and flashes in both eyes three days following second recombinant mRNA COVID-19 vaccine (Moderna). Fundus autofluorescence (FAF) illustrated speckled hyper-AF lesions surrounding right eye torpedo maculopathy site and hyper-AF lesions in the left macula.
BJGP Open
January 2025
Department of Family Medicine & Population Health, Belgium, University of Antwerp, Antwerp.
Background: Illness severity, comorbidity, fever, age and symptom duration influence antibiotic prescribing for respiratory tract infections (RTI). Non-medical determinants, such as patient expectations, also impact prescribing.
Aim: To quantify the effect of general practitioners' (GPs') perception of a patient request for antibiotics on antibiotic prescribing for RTI and investigate effect modification by medical determinants and country.
Front Public Health
January 2025
Centre for Health Economics Research and Modelling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.
Introduction: In relatively wealthy countries, substantial between-country variability in COVID-19 vaccination coverage occurred. We aimed to identify influential national-level determinants of COVID-19 vaccine uptake at different COVID-19 pandemic stages in such countries.
Methods: We considered over 50 macro-level demographic, healthcare resource, disease burden, political, socio-economic, labor, cultural, life-style indicators as explanatory factors and coverage with at least one dose by June 2021, completed initial vaccination protocols by December 2021, and booster doses by June 2022 as outcomes.
Hum Vaccin Immunother
December 2025
Department of Epidemiology and Health Statistics, School of Public Health, Southeast University, Nanjing, PR China.
Hepatitis B (Hep B) remains a critical public health issue globally, particularly in Tibet, where vaccination rates and influencing factors among college students are yet understudied. This study applies a cross-sectional design to investigate the Hep B vaccination rate among 1,126 college students in Tibet and utilizes the expanded theory of planned behavior (ETPB) to identify vaccination behavior intention (BI) and vaccination behavior (VB). Stratified cluster sampling across three universities was used to assess behavioral attitudes (BA), subjective norms (SN), perceived behavioral control (PBC), past vaccination history (PVH) and vaccination knowledge (VK), and used structural equation modeling (SEM) for model validation and multi-group comparison.
View Article and Find Full Text PDFBMC Public Health
January 2025
School of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
China witnessed an Omicron COVID-19 outbreak at the end of 2022. During this period, medical crowding and enormous pressure on the healthcare systems occurred, which might result in the occurrence of occupational burnout among healthcare workers (HCWs). This study aims to investigate the prevalence of occupational burnout and associated mental conditions, such as depressive symptoms, anxiety, PTSD symptoms, perceived social support, resilience, and mindfulness among HCWs of the Chinese mainland during the Omicron COVID-19 outbreak, and to explore the potential risk and protective factors influencing occupational burnout of HCWs.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!